Skip to main content
OpenTrials
Completed

NCT Number: NCT06938126

Effects of L-Arginine and Citrulline Malate Supplementation on Sport Performance in Physically Active Men

In this randomized, double-blind, placebo-controlled trial we investigated the effects of combined L-arginine (Arg) and citrulline-malate (CM) supplementation on aerobic, anaerobic, and high-intensity interval training in healthy, physically active men. 46 healthy, physically active men were divided into three distinct exercise protocol groups: CrossFit group, the Wingate Anaerobic Test group, and the Harvard Step Test group. The CrossFit performance assessment involved the "Cindy" workout, a high-intensity protocol composed of bodyweight exercises organized in a set sequence: 5 pull-ups, 10 push-ups, and 15 squats. Participants were instructed to perform as many rounds as possible within 20 minutes. The Wingate Anaerobic test involved a 30-second all-out cycling test on a bike ergometer, while the Harvard Step Test The Harvard Step Test was conducted using a 51 cm high platform, with participants stepping at a rate of 30 steps per minute (one second up, one second down) for five minutes or until exhaustion. Each participant attended three separate laboratory sessions. The initial session served for familiarization with the test protocol to minimize learning effects. In the second and the third sessions, participants attended two measurement sessions, conducted in randomized order and under double-blind conditions, where they received either the dietary supplementation or a placebo. Each participant acted as their control, allowing for within-subject comparisons.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–30 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Hungaria University of Sports Science

Budapest, 1124, Hungary

About this study

Consumption of dietary supplements is a common strategy among athletes aiming to optimize recovery after training or competitions and enhance athletic performance. Amino acids L-arginine (Arg) and L-citrulline (Cit) are two of the most widely used supplements in recent times. Their use as nutritional supplements or dietary supplements to improve health and athletic performance has increased dramatically, as both Arg and Cit are essential for the body's synthesis of nitric oxide (NO) and elimination of waste products such as lactate during physical activity. Because it functions as an endogenous precursor to Arg, the primary substrate of nitric oxide, Cit, a non-protein, non-essential amino acid, has attracted a lot of attention lately for its potential to improve exercise performance. Commonly, citrulline is consumed as citrulline malate (CM), which is a mixture of Cit and malic acid in ratios ranging from 1:1 to 2:1. The combined intake of Arg and CM could potentially enhance athletic performance more effectively than using either supplement alone. This synergistic benefit is attributed to Cit's role in synthesizing additional Arg, which in turn elevates NO production, enhancing blood flow and possibly reducing muscle fatigue. Supporting this hypothesis, mixed supplementation of Arg and CM was examined in a previous study and significant increases in both force exertion and fatigue resistance during a 10-minute high-intensity cycling test was found. However, while initial evidence suggests potential ergogenic benefits of combined Arg and CM supplementation, further research is needed to confirm these effects across various exercise modalities. The aim of this study was to investigate the acute effects of combined Arg and CM supplementation on anaerobic performance, aerobic performance, or both through high-intensity interval training (i.e. CrossFit) outcomes in healthy, physically active men. Based on existing research, it was hypothesized that the supplementation would enhance performance by achieving higher peak power in the anaerobic protocol and CrossFit in the CrossFit training protocol, where rapid energy production and resistance to fatigue are critical.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • being healthy, physically active with no history of injuries or illnesses at the time of measurement or within the preceding six months

Exclusion criteria

  • consumption of any dietary supplements in the last six months to avoid confounding effects

Treatment and study plan

L-Arginine and Citrulline-Malate Supplementation

Dietary Supplement

L-Arginine and Citrulline Malate supplementation was consumed as a liquid one single time to examine the acute effects on sport performance

Placebo consumption

Dietary Supplement

Consumption of placebo as a liquid

Primary outcomes

  1. Mechanical Power

    Time frame: Day 1 and Day 2

    Maximal and mean mechanical power was assessed during the Wingate Anaerobic Test under both conditions (supplementation and placebo).

  2. Fitness Score

    Time frame: Day 1 and Day 2

    During the CrossFit exercise and the Harvard Step Test the primare measure of performance was a Fitness Score, which was calculated from the rounds completed for the CrossFit exercise and from the time duration and heart rate for the Harvard Step Test.

Secondary outcomes

  1. Heart Rate

    Time frame: Day 1 and Day 2

    Maximal and mean heart rate was measured for all three exercise protolcols: The Wingate Anaerobic Test, The CrossFit Test, and the Harvard Step Test.

Sponsors and collaborators

Lead sponsor

Hungarian University of Sports Science

Other

Registry information

Official study title

Acute Effects of Combined Supplementation of L-Arginine and Citrulline Malate on Aerobic, Anaerobic, and CrossFit® Exercise Performance

Acronym: ReachSci

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Apr 22, 2025
Registry last updated
Apr 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.